Medidata Solutions

Last updated
Medidata
Type Private
Industry Life sciences
Artificial Intelligence
Clinical development technology
Software as a service
Founded1999; New York, NY
FounderGlen de Vries
Edward Ikeguchi
Tarek Sherif
Headquarters
350 Hudson Street,
New York, NY, United States
Area served
Worldwide
Key people
Tarek Sherif
(CEO, Chairman)
Vacant
(President)
ProductsMedidata Rave
Medidata Patient Cloud
Medidata Acorn AI
RevenueIncrease2.svg $636 million (2018) [1]
Number of employees
2,800 [2] (2018) [3]
Parent Dassault Systèmes
Website medidata.com

Medidata Solutions is an American technology company that develops and markets software as a service (SaaS) for clinical trials. These include protocol development, clinical site collaboration and management; randomization and trial supply management; capturing patient data through web forms, mobile health (mHealth) devices, laboratory reports, and imaging systems; quality monitor management; safety event capture; and monitoring and business analytics. Headquartered in New York City, Medidata has locations in China, Japan, Singapore, South Korea, the United Kingdom, and the United States. [4] [5] [6]

Contents

Medidata's customers include pharmaceutical, biotechnology, medical device, and diagnostic companies; academic and government institutions; contract research organizations; and other life sciences organizations around the world that develop and bring medical therapies and products to market.

History

The company was founded in June 1999 by Tarek Sherif, Glen de Vries and Ed Ikeguchi. [4] [5] [6] In 1994, de Vries and Ikeguchi created OceanTek, a startup that developed Web applications for conducting clinical trials and was the precursor to Medidata. [7] In 1999, they restarted the company as a new firm and, together with Sherif, formed Medidata, to provide online systems for designing and running clinical trials. [7] [8] In 2004, they completed a $10 million round of financing with Insight Venture Partners, [8] and were later backed by investors including Milestone Venture Partners and Stonehenge Capital Fund. [9] Ikeguchi left the company in 2008, and de Vries moved from chief technology officer to president, with Tarek as chief executive officer. [7]

On January 26, 2009, Medidata filed to raise $86 million in an initial public offering (IPO). [9] It made its IPO on the Nasdaq Stock Market on June 25, 2009, with its market capitalization at $313 million. [10] It debuted on the Nasdaq at $18 per share. [5] The company was ranked #11 on Fortune magazine's 2017 Fortune Future 50 list, [11] #51 on the Fortune 100 Fastest Growing Companies list, [12] and #59 on the Forbes list of Most Innovative Growth Companies, at a value of $3.3 billion as of May 2017. [13] In 2018, Medidata was ranked #70 on Barron's 100 Most Sustainable Companies list. [14]

In December 2019, Medidata was acquired by Dassault Systèmes. [15] Medidata now functions as a subsidiary. [16]

Acquisitions

CompanyDateBusinessReferences
Fast Track SystemsMarch 2008Clinical trial planning software [9] [17]
Clinical ForceJuly 2011SaaS-based clinical trial management systems (CTMS) [18] [19]
Patient ProfilesOctober 2014Software focused on improving clinical trial data quality [20]
IntelemageApril 2016Medical image sharing technology [21]
ChitaFebruary 2017Cloud-based content management and collaboration system [22]
MytrusApril 2017Clinical trial technology [23]
SHYFT AnalyticsJune 2018Cloud data analytics [24]
MC10October 2020Digital biomarker technology [25]

Software

Medidata offers a cloud-based platform for clients to build their own clinical trials and perform medical research. On the platform, physicians and scientists can collect and share clinical trial data. [4] [10] [26] The company helps biopharmaceutical and medical device companies run clinical trials, and streamlines the process for life science firms designing the trials. [4] [5] As of 2017, Medidata customers include 18 of the world's top 25 pharmaceutical companies, [27] with clients such as Johnson & Johnson, AstraZeneca, Amgen, Cancer Research UK, GlaxoSmithKline, Novartis and Hoffmann-La Roche. [3] [17] Clients also include biotechnology companies, government institutions, and contract research organizations. [7]

The company has two primary products. Medidata Rave EDC, its flagship product, introduced in 2001, is a single system for electronic data capture and clinical data management, allowing client data to be accessible in one place. [17] [27] [28] [29] Medidata Rave Clinical Cloud, introduced in 2013, is a platform used for data capture and management of patient-related data for clinical operations. [8] [29] [30] In February 2018, Medidata announced plans to launch virtual trials as a part of its platform's clinical trial products, allowing patients to participate remotely in drug development trials. [31]

Locations

Headquartered in New York City, [32] the company has additional offices in the United States in Boston, Massachusetts; Iselin, New Jersey; Houston, Texas; San Francisco, California; Davis, California; San Mateo, California; and Cincinnati, Ohio. Internationally, Medidata maintains offices in London, England; Düsseldorf, Germany; Tokyo, Japan; Beijing, China; Shanghai, China; Seoul, South Korea; Singapore; Pune, India and Frankfurt, Germany. [3] [29]

In September 2014, Medidata discovered that it had been the victim of a fraudulently induced transfer of nearly $4.8 million. The company filed an insurance claim for its loss, which was denied by its insurer, Federal Insurance Co., a subsidiary of Chubb Ltd. The insurer claimed that its policy only covered losses resulting from fraudulent entry or hacking into a computer system and that in this case the transfer was voluntary, while Medidata argued that the thief's actions did come within the policy's definition of covered losses. [33] [34] On July 21, 2017, a federal court in New York ruled that Medidata was entitled to coverage from Federal Insurance for the $4.8 million loss. [34] [35] Federal Insurance's appeal is pending. [36]

On January 26, 2017, Medidata filed a lawsuit in federal court in New York against five former employees and Veeva Systems Inc., in which it accused Veeva of trade secret theft. The complaint alleges that Veeva induced former Medidata employees to reveal confidential information and trade secrets that belong to Medidata. [37] [38] On August 16, 2017, the court denied Veeva's motion to compel arbitration, [39] and on September 20, 2017, Medidata filed its Second Amended Complaint, which names Veeva as the only defendant. The case is ongoing. [40]

Related Research Articles

<span class="mw-page-title-main">Dassault Systèmes</span> French Software Company

Dassault Systèmes SE is a French multinational software corporation which develops software for 3D product design, simulation, manufacturing and other 3D related products.

<span class="mw-page-title-main">Accenture</span> Irish multinational consulting company

Accenture plc is an Irish-American professional services company based in Dublin, specializing in information technology (IT) services and consulting. A Fortune Global 500 company, it reported revenues of $64.1 billion in 2023. Accenture's current clients include 91 of the Fortune Global 100 and more than three-quarters of the Fortune Global 500. As of 2022, Accenture is considered the largest consulting firm in the world by number of employees.

<span class="mw-page-title-main">Labcorp Drug Development</span> Contract research organization

Labcorp Drug Development is a contract research organization (CRO) headquartered in Burlington, North Carolina, providing nonclinical, preclinical, clinical and commercialization services to pharmaceutical and biotechnology industries. Formerly called Covance, the company is part of Labcorp, which employs more than 70,000 people worldwide. Labcorp Drug Development claims to provide the world's largest central laboratory network.

<span class="mw-page-title-main">Otsuka Pharmaceutical</span> Japanese pharmaceutical company

Otsuka Pharmaceutical Co., Ltd., abbreviated OPC, is a pharmaceutical company headquartered in Tokyo, Osaka and Naruto, Japan. The company was established August 10, 1964.

IMS Health was an American company that provided information, services and technology for the healthcare industry. IMS stood for Intercontinental Medical Statistics. It was the largest vendor of U.S. physician prescribing data. IMS Health was founded in 1954 by Bill Frohlich and David Dubow with Arthur Sackler having a hidden ownership stake. In 2010, IMS Health was taken private by TPG Capital, CPP Investment Board and Leonard Green & Partners. The company went public on April 4, 2014, and began trading on the NYSE under the symbol IMS. IMS Health was headquartered in Danbury, Connecticut.

Parexel International is an American provider of biopharmaceutical services. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process. It is the second largest clinical research organization in the world and has helped develop approximately 95% of the 200 top-selling biopharmaceuticals on the market today. The company publishes the annual Parexel R&D Statistical Sourcebook, operates the Parexel-Academy, and councils all of the top 50 biopharmaceutical and top 30 biotechnology companies.

IQVIA, formerly Quintiles and IMS Health, Inc., is an American Fortune 500 and S&P 500 multinational company serving the combined industries of health information technology and clinical research. IQVIA is a provider of biopharmaceutical development, professional consulting and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including investment strategy and management consulting services. It has a network of more than 88,000 employees in more than 100 countries and a market capitalization of US$49 billion as of August 2021. As of 2023, IQVIA was reported to be one of the world's largest contract research organizations (CRO).

<span class="mw-page-title-main">Quantcast</span> American technology company

Quantcast is an American technology company, founded in 2006, that specializes in AI-driven real-time advertising, audience insights and measurement. It has offices in the United States, Canada, Australia, Singapore, United Kingdom, Ireland, France, Germany, Italy, and Sweden.

CancerVax was an American pharmaceutical company founded in 1998 by Donald Morton. The company sought to develop a vaccine for cancer, and had candidates for melanoma reach phase III clinical trials. When those trials proved unsuccessful in 2005, the company soon underwent a reverse takeover with Micromet.

Palantir Technologies is a public American company that specializes in big data analytics. Headquartered in Denver, Colorado, it was founded by Peter Thiel, Nathan Gettings, Joe Lonsdale, Stephen Cohen, and Alex Karp in 2003. The company's name is derived from The Lord of the Rings where the magical palantíri were "seeing-stones," described as indestructible balls of crystal used for communication and to see events in other parts of the world.

Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.

American Well Corporation, doing business as Amwell, is a telemedicine company based in Boston, Massachusetts, that connects patients with doctors over secure video. Amwell sells its platform as a subscription service to healthcare providers to put their medical professionals online and its proprietary software development kits, APIs, and system integrations enable clients to embed telehealth into existing workflows utilized by providers and patients.

Kite Pharma is an American biotechnology company that develops cancer immunotherapy products, with a primary focus on genetically engineered autologous CAR T cell therapy, a cell-based therapy which relies on chimeric antigen receptors and T cells. Founded in 2009, and based in Santa Monica, California, it was acquired by Gilead Sciences in 2017.

Sprinklr is an American software company based in New York City that develops a SaaS customer experience management (CXM) platform. The company's software, also called Sprinklr, combines different applications for social media marketing, social advertising, content management, collaboration, employee advocacy, customer care, social media research, and social media monitoring.

MobiKwik is an Indian payment service provider founded in 2009 that provides a mobile phone-based payment system and digital wallet. Customers can add money to an online wallet that can be used for payments. In 2013 the Reserve Bank of India authorized the company's use of the MobiKwik wallet, and in May 2016 the company began providing small loans to consumers as part of its service.

Teladoc Health, Inc. is a multinational telemedicine and virtual healthcare company headquartered in the United States. Primary services include telehealth, medical opinions, AI and analytics, telehealth devices and licensable platform services. In particular, Teladoc Health uses telephone and videoconferencing software as well as mobile apps to provide on-demand remote medical care.

Veeva Systems Inc. is an American cloud-computing company focused on pharmaceutical and life sciences industry applications. Headquartered in Pleasanton, California, it was founded in 2007 by Peter Gassner and Matt Wallach. It works with software as a service (SaaS) in the life-science industry.

Roivant is a healthcare company focused on applying technology to drug development and building subsidiary biotech and healthcare technology companies. It was founded in 2014 by Vivek Ramaswamy.

Sophia Genetics is a data-driven medicine software company with headquarters in Lausanne, Switzerland and Boston, Massachusetts. It provides genomic and radiomic analysis for hospitals, laboratories, and biopharma institutions. The company was ranked among the 50 smartest companies by the MIT Technology Review in 2017. The company went public on the Nasdaq in 2021, floating at $1.1B.

ICON plc is an Irish headquartered Nasdaq listed multinational healthcare intelligence and clinical research organisation that provides consulting, clinical development and commercialisation services for the pharmaceutical industry. As of June 2023, ICON had approximately 41,160 employees in 108 locations spread across 53 countries.

References

  1. ↑ "Symbol Lookup from Yahoo Finance". finance.yahoo.com.
  2. ↑ "Dassault Systèmes and Medidata Solutions to Join Forces to Accelerate the Life Sciences Industry Innovation for Patient-Centric Experience Through End-to-End Collaborative Platform".
  3. 1 2 3 "High-flying tech firm expands Hammersmith HQ," ibhf.gov.uk, October 6, 2017.
  4. 1 2 3 4 Kaihan Krippendorff, "The 5-Part Formula For Growth," Fast Company , August 2, 2012.
  5. 1 2 3 4 Bertha Coombs, "Medidata IPO Bookends CEO's 'American Dream'," CNBC, June 25, 2009.
  6. 1 2 Sally Ann Flecker, "Clinically Proven," Carnegie Mellon Today, April 29, 2015.
  7. 1 2 3 4 Glen de Vries, "Dance Lessons in Life," New York Times , May 5, 2012.
  8. 1 2 3 Matthew Herper, "Rx For Software: Can Medidata Solutions Save Drug Companies Billions?" Forbes , March 3, 2014.
  9. 1 2 3 Claire Cin Miller, "OpenTable and Medidata Hope to End I.P.O. Drought," New York Times, February 2, 2009.
  10. 1 2 Scott Austin, "Medidata IPO Prices, No. 3 For Venture-Backed Companies," Wall Street Journal , June 24, 2009.
  11. ↑ "The Future 50". Fortune. Retrieved 2021-07-22.
  12. ↑ "Medidata Solutions". Fortune. Retrieved 2021-07-22.
  13. ↑ "Most Innovative Growth Companies," Forbes , May 2017.
  14. ↑ Leslie P. Norton, "Barron’s 100 Most Sustainable Companies," Barron's , February 3, 2018.
  15. ↑ "Dassault Systemes targets life sciences with $5.8 billion Medidata deal". Reuters. 12 June 2019.
  16. ↑ "Medidata acquired by French software firm Dassault Systèmes for $5.8bn". 12 June 2019.
  17. 1 2 3 Phil Taylor, "Medidata plans $86m IPO," Outsourcing-Pharma.com, January 28, 2009.
  18. ↑ Roth, Gil (20 June 2011). "Medidata To Acquire Clinical Force". Breaking News. PharmaTimes. Retrieved 2016-07-23.
  19. ↑ Nick Taylor, "Medidata plans acquisitions to continue strong profit growth," Outsourcing-Pharma.com, November 9, 2011.
  20. ↑ "Medidata Solutions Acquires Patient Profiles | Mergr". mergr.com. Retrieved 2021-08-04.
  21. ↑ "Medidata swoops on medical imaging player Intelemage". FierceBiotech. Retrieved 2021-08-04.
  22. ↑ John Kennedy, "Medidata acquires Elan IT spin-out CHITA," Silicon Republic, February 20, 2017.
  23. ↑ Jonah Comstock, "Medidata acquires Mytrus in mobile clinical trial merger," Mobi Health News, April 24, 2017.
  24. ↑ "Medidata acquires Shyft for $195M, establishes unified trial, commercialization data platform". MobiHealthNews. 2018-06-12. Retrieved 2021-08-04.
  25. ↑ "Medidata acquires MC10's digital biomarker business". MobiHealthNews. 2020-10-27. Retrieved 2021-08-04.
  26. ↑ Natasha Lindstrom, "Carnegie Mellon receives $10M gift from alum who runs global tech company," Tribune Live, December 12, 2017.
  27. 1 2 Nick Paul Taylor, "Biogen switches to Medidata Rave, tipping balance of eClinical power further still," Fierce Biotech, July 21, 2016.
  28. ↑ "Wyeth Selects Medidata Rave as Its EDC Standard," Bio IT World, November 29, 2017.
  29. 1 2 3 "Medidata Solutions," Success Story. Accessed January 25, 2018.
  30. ↑ Dhruv Vasishtha, "Using Tech To Cure Disease: Interview With Medidata President, Glen de Vries," The Wharton Journal, February 8, 2017.
  31. ↑ Stephanie Baum, "What's the future of clinical trial design? Medidata sees a blend of virtual and in-person components," Med City News, February 9, 2018.
  32. ↑ Daniel Geiger, "Medidata Close to 100K s/f Deal at 350 Hudson," Commercial Observer, September 26, 2012.
  33. ↑ "Impact of Court Ruling Chubb Unit's Crime Policy Covers 'Spoofed' Wire Transfer". Insurance Journal. 2018-07-09. Retrieved 2021-07-22.
  34. 1 2 Sam Boyer, "Judge orders Federal Insurance to pay up $4.8 million claim," Insurance Business, July 25, 2017.
  35. ↑ Jeff Sistrunk, "Medidata Covered For $4.8M Computer Fraud, Judge Rules," Law 360, July 21, 2017.
  36. ↑ John Lande, "Maybe you have cyber-insurance coverage after all," Dickinson Law, September 7, 2017.
  37. ↑ Wiessner, Daniel (2018-11-27). "Judge won't toss software firm's poaching, trade secrets claims". Reuters. Retrieved 2021-07-22.
  38. ↑ Peter Blumberg and Sarah McBride, "Veeva Turns the Tables in Fight Over Tech Hiring Barriers," Bloomberg Businessweek , July 18, 2017.
  39. ↑ "Medidata Solutions, Inc. v. Veeva Systems Inc.," New York Law Journal , August 22, 2017.
  40. ↑ "Medidata Solutions, Inc. v. Veeva Systems Inc. et al," docketalarm.com, as of February 20, 2018.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.